Singapore, Oct. 27 -- King Faisal Specialist Hospital and Research Centre will open Saudi Arabia's first facility for manufacturing genetic and cellular therapies by late 2025, a project designed to give thousands of patients access to advanced treatments at home, reduce the cost of care by an estimated eight billion riyals - about two billion dollars - by 2030, and meet roughly nine percent of the nation's demand for such therapies.

The new plant, located on the hospital's Riyadh campus, will produce CAR T-cell and stem-cell therapies, treatments that re-engineer a patient's own cells to fight cancer or repair damaged tissue. Spanning more than 5,000 square meters, the facility is designed around 16 modular clean-room clusters that can ...